From cutting dementia risk to reducing opioid addiction, a wave of 2025-2026 studies reveals that drugs like Ozempic and Wegovy may be the most versatile medications in a generation.
Merck's enlicitide, the first oral PCSK9 inhibitor, slashed LDL cholesterol as effectively as injections in a 2,909-person trial. The pill could solve the biggest barrier keeping millions from powerful cholesterol-lowering therapy.
New research reveals diabetes doesn't just raise heart disease risk. It fundamentally changes how your heart produces energy and maintains structure.
New University of Birmingham research shows flavanol-rich foods prevent vascular dysfunction from prolonged sitting, even when fitness alone cannot.
New research from Harvard reveals that sleeping with light exposure dramatically increases cardiovascular disease risk. Here's what the science says and how to protect yourself.
